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The recent report by Denton et al. [1] adds to previous well-designed negative placebo-controlled 
clinical trials of Raynaud’s phenomenon (RP) in systemic sclerosis (SSc). The primary endpoint was 
the weekly average number of RP attacks, with secondary endpoints including daily RP attack 
duration and RP severity (the single-item Raynaud’s Condition Score [RCS]), that together 
comprise the RCS diary.  The accompanying editorial, provides insightful suppositions of factors 
contributing to the disappointing performance of the RCS diary in clinical trials [2].  Given the lack 
of studies exploring patient attitudes towards the RCS diary, we investigated patient perceptions of 
the RCS diary.  Twenty-one patients fulfilling the 2013 ACR/EULAR classification criteria for SSc 
from Bath (UK), New Orleans (US) and Pittsburgh (US) received training on completion of the 
RCS diary. Participants received a sealed envelope containing a quantitative and qualitative 
questionnaire (online supplement) along with instructions to only complete the survey after 
completion of the 2-week RCS diary. The survey comprised four sections examining (i) ease of 
completion; (ii) factors influencing diary returns; (iii) ranking of factors used to derive the RCS; and 
(iv) a qualitative survey examining strengths, limitations and potential for improvement. The study 
received ethics approval at each site with all patients providing consent. Most patients (11, 52%) 
found the diary easy to complete, with only 1 considering it a significant burden. Seven (33%) 
patients reported not recording all RP attacks.  Most significantly, the majority (13, 62%) felt the 
number of RP attacks was unreflective of RP activity due to efforts taken to avoid attacks. Most 
subjects (16, 76%) reported difficulty recording the duration of attacks and the majority (13, 62%) 
felt duration of attacks was under-estimated by efforts taken to ameliorate symptoms.  When asked 
which factors influenced the overall RCS, the highest mean ranked factors (in descending order) 
were the duration of attacks, inability to use hands, inability to perform other activities and number 
of attacks. Pain, numbness, burning and tingling were the lowest mean ranked factors. The 
qualitative survey confirmed ease of completion (Quotation [Q] 1, Table 1) although the concept 
of RP “attacks” was not shared by all (Q2). The diary helps subjects to focus on RP symptoms, 
although this may result in altered behaviour (Q3-4). Patients do not document all attacks (Q5-6) 
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and report frustration at an inability to capture relevant contributing external factors (Q7-8); 
particularly triggers and behavioural methods that directly influence diary returns (Q9). Suggestions 
included capturing emotional distress (Q10), recording circumstances surrounding attacks (Q11) 
and the development of wearable devices for remote monitoring (Q12). The patient experiences of 
the RCS diary captured in this study provide insight on its performance in clinical trials and could 
be used to support the development of novel approaches to assessing SSc-RP.  The RCS diary is 
not over-burdensome but patients do not report all attacks and have difficulty recording duration 
of attacks. The RCS diary does not allow for the considerable efforts taken by patients to avoid or 
ameliorate symptoms and may not accurately reflect the true severity and impact of SSc-RP.   
Table 1. Quotations from qualitative survey evaluating patient experiences of RCS diary 
Q Supporting quotation 
1 It was fairly easy to complete 
2 I am still not 100% sure that I know what an "ATTACK" is and make my assessment on 
how cold my hands are.  
3 It made me more aware of attacks, made me look at my hands in different situations and if I 
needed to, I could do something about getting my hands back to normal circulation 
4 It made me more aware of the triggers. I am convinced that change and stress are significant 
5 Some of my Raynaud’s attacks were so insignificant that they weren’t worth reporting. I put 
these dates down as having no attacks that day 
6 I know I had several smaller attacks that I did not record because they were too short 
7 I felt I had to make 0 on the RCS but it didn’t capture all of the inconvenient...things I had to 
do on those days to avoid having any attacks (or) what I was doing when I had attacks. 
8 (The RCS diary) Did not take into account what I was doing that day. Was I outside more? 
Did I need to use my hands in colder environments? 
9 Duration is so subjective I feel….Most long durations for me are when I’m out of my house 
and don’t respond promptly with heated pillows etc.” 
10 Consider adding a question to identify the effect on the person’s emotional well-being” 
11 I think more info(rmation) is required....i.e. what you were doing at the time, what the 
temperature was like at the time, or what was causing the stress at the time. 
12 I think in order to get an accurate number of attacks... I feel you need some sort of monitor 
to register the attacks as they happen .... I don't know if the diaries really tells all! 
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